Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,250,720 papers from all fields of science
Search
Sign In
Create Free Account
Omnitarg
Known as:
Omnitarg, 2C4
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
pertuzumab
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
Peptide Vaccines of the HER-2/neu Dimerization Loop Are Effective in Inhibiting Mammary Tumor Growth In Vivo1
S. Allen
,
J. Garrett
,
+6 authors
P. Kaumaya
Journal of Immunology
2007
Corpus ID: 2664070
Human epidermal growth factor receptor-2 (HER-2)/neu (ErbB2), a member of the epidermal growth factor family of receptors, is…
Expand
Highly Cited
2007
Highly Cited
2007
Sensitivity to pertuzumab (2C4) in ovarian cancer models: cross-talk with estrogen receptor signaling
P. Mullen
,
D. Cameron
,
M. Hasmann
,
J. Smyth
,
S. Langdon
Molecular Cancer Therapeutics
2007
Corpus ID: 3765647
Pertuzumab (Omnitarg, rhuMab 2C4) is a humanized monoclonal antibody, which inhibits HER2 dimerization. Because it has shown some…
Expand
2007
2007
[177Lu]pertuzumab: experimental therapy of HER-2-expressing xenografts.
M. Persson
,
L. Gedda
,
+4 authors
J. Carlsson
Cancer Research
2007
Corpus ID: 38564005
Pertuzumab (Omnitarg) is a novel antibody against HER-2, domain II. HER-2 is a tyrosine kinase receptor that is overexpressed in…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE